Yi Zeng

1.7k total citations
30 papers, 1.3k citations indexed

About

Yi Zeng is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Yi Zeng has authored 30 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 12 papers in Hematology and 7 papers in Oncology. Recurrent topics in Yi Zeng's work include Immune Cell Function and Interaction (14 papers), Immunotherapy and Immune Responses (12 papers) and Hematopoietic Stem Cell Transplantation (10 papers). Yi Zeng is often cited by papers focused on Immune Cell Function and Interaction (14 papers), Immunotherapy and Immune Responses (12 papers) and Hematopoietic Stem Cell Transplantation (10 papers). Yi Zeng collaborates with scholars based in United States, China and France. Yi Zeng's co-authors include Emmanuel Katsanis, Hanping Feng, Michael W. Graner, Luke Whitesell, Nicolas Larmonier, Marilyn Marron, Samita Andreansky, Xinchun Chen, Anna Likhacheva and Jessica Cantrell and has published in prestigious journals such as Blood, International Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Yi Zeng

30 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Zeng United States 19 927 524 425 223 117 30 1.3k
Chandra Sekhar Boddupalli United States 13 665 0.7× 328 0.6× 492 1.2× 233 1.0× 90 0.8× 19 1.3k
Matteo Giovanni Carrabba Italy 15 661 0.7× 412 0.8× 435 1.0× 266 1.2× 59 0.5× 48 1.1k
Maya C. André Germany 17 441 0.5× 275 0.5× 355 0.8× 211 0.9× 105 0.9× 30 925
Lap-Ping Chung United Kingdom 21 585 0.6× 423 0.8× 297 0.7× 233 1.0× 47 0.4× 27 1.4k
Frances Santiago‐Schwarz United States 20 1.1k 1.2× 312 0.6× 219 0.5× 133 0.6× 41 0.4× 44 1.4k
Rachael M. Lane Australia 10 680 0.7× 744 1.4× 145 0.3× 241 1.1× 54 0.5× 16 1.3k
Carsten Berges Germany 15 304 0.3× 351 0.7× 189 0.4× 274 1.2× 47 0.4× 25 926
Nele Berghmans Belgium 19 369 0.4× 288 0.5× 260 0.6× 96 0.4× 46 0.4× 47 875
Ken Sato Japan 14 433 0.5× 496 0.9× 197 0.5× 200 0.9× 26 0.2× 43 1.0k
Paul Hobby United Kingdom 16 954 1.0× 218 0.4× 344 0.8× 72 0.3× 39 0.3× 24 1.3k

Countries citing papers authored by Yi Zeng

Since Specialization
Citations

This map shows the geographic impact of Yi Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Zeng more than expected).

Fields of papers citing papers by Yi Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Zeng. The network helps show where Yi Zeng may publish in the future.

Co-authorship network of co-authors of Yi Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Zeng. A scholar is included among the top collaborators of Yi Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Zeng. Yi Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiu, Yue, et al.. (2025). Hepatitis B core-related antigen as a promising serological marker for monitoring hepatitis B virus cure. World Journal of Hepatology. 17(1). 98658–98658. 1 indexed citations
2.
Hoffman, Emely A., et al.. (2020). Bendamustine with total body irradiation conditioning yields tolerant T-cells while preserving T-cell-dependent graft-versus-leukemia. OncoImmunology. 9(1). 1758011–1758011. 10 indexed citations
3.
4.
Zeng, Yi, et al.. (2019). Acute pulmonary embolism in a child with ANCA-negative idiopathic pulmonary capillaritis. Saudi Medical Journal. 40(6). 610–613. 2 indexed citations
5.
Katsanis, Emmanuel, et al.. (2018). Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide/Bendamustine in Pediatric and Young Adult Patients with Hematologic Malignancies. Biology of Blood and Marrow Transplantation. 24(10). 2034–2039. 26 indexed citations
6.
Hoffman, Emely A., et al.. (2018). Bendamustine with Total Body Irradiation Limits Murine Graft-versus-Host Disease in Part Through Effects on Myeloid-Derived Suppressor Cells. Biology of Blood and Marrow Transplantation. 25(3). 405–416. 11 indexed citations
7.
Zeng, Yi & Emmanuel Katsanis. (2017). Potential niche indications for blinatumomab as a bridge to hematopoietic cell transplantation. Bone Marrow Transplantation. 52(12). 1671–1673. 4 indexed citations
8.
9.
10.
Hoffman, Emely A., et al.. (2016). Post‐transplant bendamustine reduces GvHD while preserving GvL in experimental haploidentical bone marrow transplantation. British Journal of Haematology. 174(1). 102–116. 24 indexed citations
11.
Wang, Haiyan, Ye‐Sheng Wei, Yi Zeng, et al.. (2014). The association of polymorphisms of TLR4 and CD14genes with susceptibility to sepsis in a Chinese population. BMC Medical Genetics. 15(1). 123–123. 29 indexed citations
12.
Zeng, Yi, et al.. (2014). Activated MHC-mismatched T helper-1 lymphocyte infusion enhances GvL with limited GvHD. Bone Marrow Transplantation. 49(8). 1076–1083. 12 indexed citations
13.
Zhou, Qiang, Rui Peng, Xiao Wu, et al.. (2010). The density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer. Journal of Translational Medicine. 8(1). 13–13. 173 indexed citations
14.
Larmonier, Nicolas, Marilyn Marron, Yi Zeng, et al.. (2006). Tumor-derived CD4+CD25+ regulatory T cell suppression of dendritic cell function involves TGF-β and IL-10. Cancer Immunology Immunotherapy. 56(1). 48–59. 181 indexed citations
15.
Zeng, Yi, Xinchun Chen, Nicolas Larmonier, et al.. (2006). Natural killer cells play a key role in the antitumor immunity generated by chaperone‐rich cell lysate vaccination. International Journal of Cancer. 119(11). 2624–2631. 29 indexed citations
16.
Chen, Xinchun, Yi Zeng, Gang Li, et al.. (2006). Peritransplantation Vaccination with Chaperone-Rich Cell Lysate Induces Antileukemia Immunity. Biology of Blood and Marrow Transplantation. 12(3). 275–283. 7 indexed citations
17.
Zeng, Yi, Michael W. Graner, & Emmanuel Katsanis. (2005). Chaperone-rich cell lysates, immune activation and tumor vaccination. Cancer Immunology Immunotherapy. 55(3). 329–338. 34 indexed citations
18.
Zeng, Yi, Michael W. Graner, Hanping Feng, Gang Li, & Emmanuel Katsanis. (2004). Imatinib mesylate effectively combines with chaperone‐rich cell lysate‐loaded dendritic cells to treat bcr‐abl+ murine leukemia. International Journal of Cancer. 110(2). 251–259. 28 indexed citations
19.
Graner, Michael W., Yi Zeng, Hanping Feng, & Emmanuel Katsanis. (2003). Tumor-derived chaperone-rich cell lysates are effective therapeutic vaccines against a variety of cancers. Cancer Immunology Immunotherapy. 52(4). 226–234. 71 indexed citations
20.
Zeng, Yi, Hanping Feng, Michael W. Graner, & Emmanuel Katsanis. (2003). Tumor-derived, chaperone-rich cell lysate activates dendritic cells and elicits potent antitumor immunity. Blood. 101(11). 4485–4491. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chandra Sekhar Boddupalli Breakdown of academic impact, for papers by Matteo Giovanni Carrabba Breakdown of academic impact, for papers by Maya C. André Breakdown of academic impact, for papers by Lap-Ping Chung Breakdown of academic impact, for papers by Frances Santiago‐Schwarz Breakdown of academic impact, for papers by Rachael M. Lane Breakdown of academic impact, for papers by Carsten Berges Breakdown of academic impact, for papers by Nele Berghmans Breakdown of academic impact, for papers by Ken Sato Breakdown of academic impact, for papers by Paul Hobby
Rankless by CCL
2026